Health Canada - Federal department responsible for drug approvals and health regulation in Canada
显示 2026 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| BIO-APIXABAN | biomed pharma | Marketed | Sep 21, 2022 | Marketed |
| ENEMEEZ | quest products, llc | Marketed | Sep 21, 2022 | Marketed |
| M-APIXABAN | mantra pharma inc | Marketed | Sep 21, 2022 | Marketed |
| JAMP APIXABAN | Jamp Pharma Corporation | Marketed | Sep 20, 2022 | Marketed |
| TARO-SUNITINIB | Taro Pharmaceuticals Inc | Marketed | Sep 20, 2022 | Marketed |
| JAMP APIXABAN | Jamp Pharma Corporation | Marketed | Sep 20, 2022 | Marketed |
| TARO-SUNITINIB | Taro Pharmaceuticals Inc | Marketed | Sep 20, 2022 | Marketed |
| COMPLIMENTS CONCENTRATED CONCENTRÉE ULTRA BLEACH DISINFECTANT DÉSINFECTANT EAU DE JAVEL ULTRA | KIK HOLDCO COMPANY INC. DBA / S/N LAVO | Marketed | Sep 19, 2022 | Marketed |
| PRZ-ATORVASTATIN | pharmaris canada inc | Marketed | Sep 19, 2022 | Marketed |
| PRZ-ATORVASTATIN | pharmaris canada inc | Marketed | Sep 19, 2022 | Marketed |
| PRZ-ATORVASTATIN | pharmaris canada inc | Marketed | Sep 19, 2022 | Marketed |
| PRZ-ATORVASTATIN | pharmaris canada inc | Marketed | Sep 19, 2022 | Marketed |
| TABRECTA | novartis pharmaceuticals canada inc | Marketed | Sep 16, 2022 | Marketed |
| TABRECTA | novartis pharmaceuticals canada inc | Marketed | Sep 16, 2022 | Marketed |
| PEMETREXED DISODIUM FOR INJECTION | AURO PHARMA INC | Marketed | Sep 15, 2022 | Marketed |
| NORWELL PRO SPECIALIST | AGRISAN SPECIALTY CHEMICAL & PHARMACEUTICAL (A DIVISION OF AGRISAN INC) | Marketed | Sep 15, 2022 | Marketed |
| PEMETREXED DISODIUM FOR INJECTION | AURO PHARMA INC | Marketed | Sep 15, 2022 | Marketed |
| COMIRNATY | BioNTech Manufacturing GmbH | Cancelled Post Market | Sep 15, 2022 | Cancelled Po... |
| ACID CONCENTRATE A1270 | chief medical supplies ltd | Marketed | Sep 15, 2022 | Marketed |
| ESPEROCT | Novo Nordisk Canada Inc | Marketed | Sep 15, 2022 | Marketed |
